COMMUNIQUÉS West-GlobeNewswire

IBA lance QUASAR® GRID3D Advantage, un système d'analyse de distorsion d'image

03/05/2025 - 16:30

Nouvelle norme pour l'assurance qualité de la distorsion de l'image pour la radiothérapie guidée par résonnance magnétique et la simulation de plan de traitement Louvain-la-Neuve, Belgique, le 3 mai 2025 – IBA (Ion Beam [...]

IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System

03/05/2025 - 16:30

New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning Louvain-la-Neuve, Belgium, 3 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world [...]

Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025

03/05/2025 - 13:00

Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and Improvement in Beta Cell Function for People with Type 2 Diabetes MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) -- [...]

Javy Protein Coffee Under Review: Best Protein Coffee with Premium Ingredients by Javy Protein Coffee

03/05/2025 - 10:45

Discover why Javy Protein Coffee is the best protein coffee for energy, recovery, and flavor. Fast, convenient, zero sugar—perfect for fitness lovers and busy mornings. Summerville, South Carolina, May 03, 2025 (GLOBE [...]

SlimJaro Canada, Australia, UK, Reviews, Official Website, Discount Code, Trustpilot Complaints

03/05/2025 - 11:35

Lakeland, FL, May 03, 2025 (GLOBE NEWSWIRE) -- SlimJaro Canada: The Revolutionary Fat-Burning Formula Redefining Weight Management: Imagine a world where shedding stubborn fat doesn’t involve grueling diets, endless gym [...]

INP and Fight For Life Club Foundation Make History: Two Pediatric Living Donor Liver Transplants in One Week

03/05/2025 - 03:26

Dallas, Texas, May 02, 2025 (GLOBE NEWSWIRE) -- In a historic medical achievement, the National Institute of Pediatrics (INP), in collaboration with the Fight For Life Club Foundation , has successfully performed two [...]

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

03/05/2025 - 03:30

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in [...]

IBA lance myQA Blue Phantom³ pour l'assurance qualité en radiothérapie

02/05/2025 - 20:15

L'offre de nivellement automatique la plus rapide du marché Intégration aisée avec tous les accélérateurs linéaires Louvain-la-Neuve, Belgique, le 2 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader [...]

IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

02/05/2025 - 20:15

Fastest automatic levelling offering on the market Seamless integration with all linear accelerators Louvain-la-Neuve, Belgium, 2 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle [...]

Just Blood Uncovers New Blood Testing Technology

02/05/2025 - 21:08

Lab Expert Ryan El-Hosseiny Shut Down Times Square to Set the Record Straight NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- In a much-anticipated live demonstration on April 30, 2025, Laboratory expert and entrepreneur [...]

Pacific Health Care Organization, Inc. Reports its First Quarter 2025 Financial Results

02/05/2025 - 21:18

Irvine, CA, May 02, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q [...]

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

02/05/2025 - 21:45

WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that, following the Company’s recent press release highlighting the Direct Registration [...]

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

02/05/2025 - 22:00

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging and AI algorithms to [...]

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:00

WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of [...]

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

02/05/2025 - 22:01

SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte [...]

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/05/2025 - 22:05

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX ), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company [...]